Protagonist Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (23)

View All

Latest Posts

About This Stock More About This Stock
Chart Of The Day: Protagonist Therapeutics - Wide Opinions
Article By: Jim Van Meerten
Friday, June 9, 2023 10:20 AM EDT
100% technical buy signals 10 new highs and up 17.87% in the last month 173.50+ Weighted Alpha
In this article: PTGX
Read
Spectrum (SPPI) Earnings And Sales Beat Estimates In Q1
Article By: Zacks Investment Research
Saturday, May 5, 2018 9:05 PM EDT
Spectrum Pharma’s shares have underperformed the industry so far this year. The stock has lost 16.5% against the industry’s decline of 5%. Plus more news on Amgen, Ligand Pharmaceuticals and Protagonist Therapeutics.
In this article: SPPI, AMGN, LGND, PTGX
Read
Protagonist Therapeutics, Inc. Shares Fell 54% Yesterday After Abandoning Phase 2 Trial Of Lead Drug
Article By: TickerTV
Thursday, March 29, 2018 11:33 AM EDT
Shares of Protagonist Therapeutics dropped 54% in after-hours trading on Tuesday after announcing it would discontinue phase 2b Propel trial.
In this article: PTGX
Read
5 Breakout Stocks Generating Exceptional Returns
Article By: Swarup Gupta
Friday, December 15, 2017 11:43 AM EDT
Picking breakout stocks is probably one of the most popular techniques used by active investors. The logic behind this kind of stock selection is to determine stocks that are trading within a narrow channel.
In this article: NUAN, UEPS, TLYS, PTGX, LPG
Read
Protagonist Therapeutics, Inc. Shares Soared After Company Announced Agreement With Janssen For PTG-200
Article By: TickerTV
Wednesday, May 31, 2017 10:54 AM EDT
Protagonist Therapeutics, Inc., yesterday before the market opened announced a worldwide agreement with Janssen Biotech Inc. This made the stock to close trading yesterday at $11.82.
In this article: PTGX
Read
All Posts

Latest Tweets for $PTGX

No tweets yet!

PARTNER HEADLINES